These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 15764358)
1. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'. Hildebrandt B; Hegewisch-Becker S; Kerner T; Nierhaus A; Bakhshandeh-Bath A; Janni W; Zumschlinge R; Sommer H; Riess H; Wust P; Int J Hyperthermia; 2005 Mar; 21(2):169-83. PubMed ID: 15764358 [TBL] [Abstract][Full Text] [Related]
2. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies. Hegewisch-Becker S; Braun K; Otte M; Corovic A; Atanackovic D; Nierhaus A; Hossfeld DK; Pantel K Clin Cancer Res; 2003 Jun; 9(6):2079-84. PubMed ID: 12796371 [TBL] [Abstract][Full Text] [Related]
3. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia. von Ardenne M Strahlenther Onkol; 1994 Oct; 170(10):581-9. PubMed ID: 7974169 [TBL] [Abstract][Full Text] [Related]
4. Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model. Robins HI; Grossman J; Davis TE; AuBuchon JP; Dennis W Cancer Res; 1983 May; 43(5):2018-22. PubMed ID: 6831432 [TBL] [Abstract][Full Text] [Related]
5. A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device. Robins HI; Dennis WH; Neville AJ; Shecterle LM; Martin PA; Grossman J; Davis TE; Neville SR; Gillis WK; Rusy BF Cancer Res; 1985 Aug; 45(8):3937-44. PubMed ID: 4016761 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of systemic tolerance of 42.0 degrees C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A Phase-I study. Steinhausen D; Mayer WK; von Ardenne M Strahlenther Onkol; 1994 Jun; 170(6):322-34. PubMed ID: 8023241 [TBL] [Abstract][Full Text] [Related]
7. Current devices for high-performance whole-body hyperthermia therapy. Jia D; Liu J Expert Rev Med Devices; 2010 May; 7(3):407-23. PubMed ID: 20420562 [TBL] [Abstract][Full Text] [Related]
8. Whole body hyperthermia in the treatment of neoplastic disease. Robins HI; Hugander A; Cohen JD Radiol Clin North Am; 1989 May; 27(3):603-10. PubMed ID: 2648462 [TBL] [Abstract][Full Text] [Related]
9. Changes in hepatic blood flow during whole body hyperthermia. Deja M; Ahlers O; Macguill M; Wust P; Hildebrandt B; Riess H; Kerner T Int J Hyperthermia; 2010; 26(2):95-100. PubMed ID: 20146563 [TBL] [Abstract][Full Text] [Related]
10. Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Wiedemann GJ; Robins HI; Katschinski DM; Mentzel M; D'Oleire F; Kutz M; Wagner T Anticancer Res; 1997; 17(4B):2899-902. PubMed ID: 9329558 [TBL] [Abstract][Full Text] [Related]
11. Whole body hyperthermia supplemented with urotropin in the treatment of malignant tumors. Ismail-Zade RS Exp Oncol; 2005 Mar; 27(1):61-4. PubMed ID: 15812360 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer]. Liu XL; Ma F; Zhou CX; Huang M; Gong HY; Xie GY; Hu CH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):350-2. PubMed ID: 16859121 [TBL] [Abstract][Full Text] [Related]
13. Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. Robins HI; D'Oleire F; Grosen E; Spriggs D Anticancer Res; 1997; 17(4B):2891-4. PubMed ID: 9329556 [TBL] [Abstract][Full Text] [Related]
14. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study. Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635 [TBL] [Abstract][Full Text] [Related]
15. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models. Kraybill WG; Olenki T; Evans SS; Ostberg JR; O'Leary KA; Gibbs JF; Repasky EA Int J Hyperthermia; 2002; 18(3):253-66. PubMed ID: 12028640 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial on the effectiveness of mild water-filtered near infrared whole-body hyperthermia as an adjunct to a standard multimodal rehabilitation in the treatment of fibromyalgia. Brockow T; Wagner A; Franke A; Offenbächer M; Resch KL Clin J Pain; 2007 Jan; 23(1):67-75. PubMed ID: 17277647 [TBL] [Abstract][Full Text] [Related]
17. Effects of hyperthermia on the peripheral nervous system: a review. Haveman J; Van Der Zee J; Wondergem J; Hoogeveen JF; Hulshof MC Int J Hyperthermia; 2004 Jun; 20(4):371-91. PubMed ID: 15204519 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice. Udagawa Y; Nagasawa H; Kiyokawa S Anticancer Res; 1999; 19(5B):4125-30. PubMed ID: 10628363 [TBL] [Abstract][Full Text] [Related]